Hydrogen fuel cell leader Plug Power (NASDAQ: PLUG) had a big week last week, announcing multiple corporate partnerships to manufacture fuel cell parts, pioneer fuel cell use in airplanes, and bring to market a hydrogen-powered fuel cell van. Plug's biggest news -- its prediction that revenues will leap to more than $800 million next year and more than triple that number over the following three years -- helped to raise analyst price targets and lift shares of Plug Power. It also sparked stock analyst initiations of peer fuel cell companies Ballard Power (NASDAQ: BLDP) and Bloom Energy (NYSE: BE) -- but not of FuelCell Energy (NASDAQ: FCEL).
In this article, we discuss the 9 best hydrogen fuel cell stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Hydrogen Fuel Cell Stocks To Buy. Hydrogen fuel cell technology is set to grow as governments around the world get serious about solving the climate […]
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 and hedging or reducing many of their long positions. Some fund managers are betting on Dow […]
Shares of Moderna (NASDAQ: MRNA) were rising 3.3% as of 10:59 a.m. EDT on Monday. This gain came after the Financial Times reported new forecasts from health data analytics company Airfinity that project Moderna's COVID-19 vaccine could generate sales of $38.7 billion in 2022. Investors might be justified in jumping aboard the Moderna train if Airfinity's 2022 estimate is right.
Apple has unveiled a host of new products at its “Unleashed” virtual event on Monday. The star of the show is an updated MacBook Pro, which will include a new M1 Pro or M1 Max chip. The new MacBooks will come alongside the updated MacBook Air, Pro, Mac Mini and iMac that were released with Apple’s M1 chip – the first “Apple Silicon” processor designed by Apple itself rather than Intel.
On a mixed day for the stock market -- the Dow is down a small fraction of a percent, while the Nasdaq is up a slightly larger fraction of a percent -- Facebook (NASDAQ: FB) stock is shining today, with its shares rising 2.2% as of 11:15 a.m. EDT. You all know the story on Facebook of late. For much of this month, the stock's been lagging as first The Wall Street Journal, then The New York Times, and finally the U.S. Congress itself have been critical of its business practices.
The stock market was relatively flat on Monday morning, but real estate specialist Zillow Group (NASDAQ: Z) (NASDAQ: ZG) was a major underperformer. The reason for today's drop is that the company announced it is suspending its Zillow Offers iBuying program for the rest of the year. If you aren't familiar, this is the part of Zillow's business that buys real estate directly from sellers, makes repairs, and then resells the homes.
Movie theaters have their strongest 14-day run in 20 months. The fourth quarter is off to a strong start.
As the fears of the memory chip price declines start to materialize, the latest slump of Micron Technology (NASDAQ: MU) completely erased the yearly gains. While short-term headwinds shouldn't be a reason to "panic-sell, "prospective buyers should carefully evaluate upsides vs. downsides in their investment time frame.
Shares of MannKind (NASDAQ: MNKD), a company working to develop inhaled therapeutics, were down 18% as of 11:59 a.m. EDT on Monday after an inspection issue derailed its hopes of approval for Tyvaso DPI, a lung disease therapy it developed with United Therapeutics (NASDAQ: UTHR). According to United Therapeutics' Securities and Exchange Commission filings, it owns two patents for treating PAH through inhalation that expire in 2024. The Food and Drug Administration's complete response letter didn't cite issues with MannKind's operations or even the clinical data submitted by the two companies.
Coal stock Peabody Energy (NYSE: BTU) shot up Monday morning, having jumped as much as 20.6% as of 11:10 a.m. EDT after the market took a liking to the coal producer's preliminary numbers. A deeper dive into the numbers, though, reflects muted year-over-year growth, which means there was more to Peabody Energy stock's rally this morning. The biggest number from Peabody Energy's preliminary results that caught the market's attention is its coal sales, which crossed $900 million during the quarter to levels last seen nearly seven quarters ago.
(Bloomberg) -- Zillow Group Inc. shares fell as much as 6.8% in premarket trading Monday after the online real estate firm said it would stop buying new homes and work to clear a backlog of properties it already has.Most Read from BloombergGoogle’s Biggest Moonshot Is Its Search for a Carbon-Free FutureThe Biggest Public Graveyard in the U.S. Is Becoming a ParkGoogle’s CEO: ‘We’re Losing Time’ in the Climate FightWhy Buying a Second or Even Third Home Is Becoming More Popular Than EverHate-Speec
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks. If you want to skip our detailed analysis of Wood’s history, investment philosophy, and hedge fund performance, go directly to Cathie Wood’s Top 5 Small-Cap Stock Picks. Catherine Wood is an American millionaire investor, who founded ARK Investment Management in 2014. She serves […]
Bad news the company received today from the FDA surprised investors more than it probably should have.
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.
Shares of the biotech companies are slumping after the failure of a trial for its treatment for amyotrophic lateral sclerosis.
Ocugen (NASDAQ: OCGN) shares took center stage earlier this year when the biotech joined the coronavirus vaccine race. The company partnered with India's Bharat Biotech to co-develop and co-commercialize Bharat's vaccine candidate -- Covaxin -- in the U.S. As a result, Ocugen shares soared as much as 763% in about six weeks. Now, some investors might be wondering if Ocugen will hang onto this positive momentum -- or whether the stock is heading for a crash.
This week I see Netflix (NASDAQ: NFLX), AT&T (NYSE: T), and Robinhood Markets (NASDAQ: HOOD) as vulnerable investments in the near term. It doesn't help that Netflix disappointed investors with its previous quarterly update three months ago.
The Yahoo Finance panel breaks down what to expect in a stacked week for the market as we await Netflix, Airlines, and Tesla earnings. Watch as the panel discusses how these most recent earnings could shape the market.
In this article, we discuss the top 10 dividend stock picks of billionaire Ken Fisher. If you want to skip our detailed analysis of these stocks, go directly to Billionaire Ken Fisher’s Top 5 Dividend Stock Picks. Ken Fisher is one of the most well-known hedge fund managers on Wall Street. The portfolio of his […]